Phenylbutazone 200 MG/ML Injectable Solution [Equi-Phar]

Known as: Equi-Phar 200 MG/ML Injectable Solution, PHENYLBUTAZONE 200 mg in 1 mL INTRAVENOUS INJECTION [EQUI-PHAR] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1951-2016
012319512015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND The prevalence of the use of secondary prevention cardiovascular medications is lower among women than men, but it is… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2014
2014
Psychiatry remains the most subjective field in medicine. This has probably been the greatest barrier to improving the accuracy… (More)
Is this relevant?
2012
2012
The following are the abstracts from the scientific presentations of the 10th Annual Congress of the Asia-Pacific Association of… (More)
Is this relevant?
2010
2010
UNLABELLED 3, 3'-diindolylmethane (DIM) modulates estrogen metabolism and acts as an anti-androgen which down-regulates the… (More)
Is this relevant?
2007
2007
Americans made 1.17 billion visits to ambulatory clinics and emergency departments in 2005. Acute respiratory infections (i.e… (More)
Is this relevant?
2006
2006
The subcutaneous administration of chlorpromazine (CPZ) caused a dose response increase in plasma glucose and cyclic AMP levels… (More)
Is this relevant?
2005
2005
Introduction Epilepsy is a common medical and social disorder or group of disorders with unique characteristics. Epilepsy is… (More)
Is this relevant?
1998
1998
This paper presents a case study of a machine-aided knowledge discovery process within the general area of drug design. Within… (More)
  • figure 4
Is this relevant?
1983
1983
Medical College, Valhalla, for research on naloxone (N-allyl-14-hydroxydtiy-dro-nor-morphinone), a narcotic antagonist. The award… (More)
  • figure 1
Is this relevant?